MCUJFOTCPharmaceutical PreparationsFiscal year ends December 31
MEDICURE INC
Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 20-F on Apr 24, 2026
$3.10+0.12 (+4.07%)
Close on Oct 19, 2026
Share price
+$2.32 (+297.4%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
MEDICURE INC grew revenue 1.0% to C$21.91M over fiscal 2024.
Revenue
C$21.91M
+1.0% vs. a year earlier
EPS, diluted
-0.10 CAD
FY2024
Key statistics
Valuation at the latest close; fundamentals over fiscal 2024, balances at Mar 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- C$21.91M
- EPS, diluted
- -0.10 CAD
- Diluted shares
- 10M
Valuation needs the share price. It fills in once daily prices are connected and converted from CAD.
Eleven years at a glance
Fiscal years 2014 to 2024, CAD
Revenue
C$21.91M+1.0% YoY
Gross profit
C$13.09M-6.4% YoY
Operating income
–
EPS, diluted
-0.10 CAD
Reported period